ATI RN Pharmacology 2023 retake 1 | Nurselytic

Questions 59

ATI RN

ATI RN Test Bank

ATI RN Pharmacology 2023 retake 1 Questions

Extract:


Question 1 of 5

A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?

Correct Answer: A

Rationale: The correct answer is A: WBC count. Filgrastim is a medication that stimulates the production of white blood cells (WBCs).
Therefore, monitoring the WBC count is essential to evaluate the effectiveness of the treatment. An increase in WBC count indicates the medication is working to boost the immune system. INR (
B) is not relevant as it measures blood clotting time. BUN (
C) assesses kidney function, not related to filgrastim. Potassium level (
D) is important but not specific to evaluating filgrastim effectiveness.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

Access More Questions!

ATI RN Basic


$89/ 30 days

 

ATI RN Premium


$150/ 90 days